B lymphoblastic leukaemia or lymphoma with t(9:22) (q34;q11.2); BCR-ABL1 (Q39068): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| (One intermediate revision by the same user not shown) | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Linked ICD 10 | |||||||||||||||
| Property / Linked ICD 10: C81-C96 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 04:22, 13 August 2026
A precursor lymphoid neoplasm which is composed of B-lymphoblasts and carries a translocation between the BCR gene on chromosome 22 and the ABL1 gene on chromosome 9. It results in the production of the p190 kd or p210 kd fusion protein. It has an unfavorable clinical outcome.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 2A70.1 |
||
| English | B lymphoblastic leukaemia or lymphoma with t(9:22) (q34;q11.2); BCR-ABL1 |
A precursor lymphoid neoplasm which is composed of B-lymphoblasts and carries a translocation between the BCR gene on chromosome 22 and the ABL1 gene on chromosome 9. It results in the production of the p190 kd or p210 kd fusion protein. It has an unfavorable clinical outcome. |
Statements
CID11:2A70.1
0 references
dki-india-2A70.1
0 references
Concluído
0 references
13 August 2026
0 references
